They are: • Bayer Industry Services GmbH &amp, Co. OHG The company today ... the growth spurred new fields of business. The establishment of a major research capability by Carl Duisberg during ...
Bayern-Chemie is a wholly owned subsidiary of MBDA and is a world leader in guided missile and space propulsion technology. Bayern-Chemie has more than 60 years of experience in the development and ...
These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of ...
The newly restructured Makroform GmbH (D-64293 Darmstadt), a joint ... We offer daily updated business news and reports, in-depth market analysis, polymer prices and other services for the ...
Bayer expects its pharmaceutical business to return to growth in 2027 as the launch new therapies is expected to offset ...
BERLIN--(BUSINESS WIRE)--Bayer ... of over 100 years in radiology, Bayer is committed to providing excellence – from innovative products to high-quality services – to support efficient ...
“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...
Growth is on the horizon for German drug conglomerate Bayer (BAYRY), despite “falling sales of its blockbuster blood thinner Xarelto,”amid ...
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the facility to toxic chemicals made by the company’s Monsanto unit caused brain ...
ZURICH, Jan 14 (Reuters) - Bayer (BAYGn.DE), opens new tab will ... be among the top five in the world in the pharmaceutical business, but in this business, size is not the decisive factor.
as the German group strengthens its cardiovascular business with smaller deals. Bayer acquires rights to Cytokinetics' heart drug in Japan Some Bayer investors say CEO Bill Anderson should speed ...